Cephalon to Hold Public Memorial Service to Celebrate the Life of Company Founder, Frank Baldino, Jr., Ph.D.

FRAZER, Pa., Jan. 24, 2011 /PRNewswire/ -- Cephalon, Inc., (Nasdaq: CEPH) will hold a public memorial service to celebrate the life of the company's founder and late Chairman and CEO on February 1, 2011, at 6:00 p.m. at The Franklin Institute, 222 North 20^th Street, Philadelphia, Pennsylvania.

Dr. Baldino founded Cephalon in 1987 and led the company from a privately held startup to one of the top ten biotechnology companies in the world. He was a recognized pioneer in the biotechnology industry; but, his most enduring legacy will be his accomplishments as a civic leader, a mentor, a philanthropist, and most notably, a husband and father.

Dr. Baldino died on December 16, 2010, from complications associated with leukemia. He was 57 years old.

Visit http://www.cephalon.com/frankbaldinojr/ to view Dr. Baldino's obituary, donate to a cause in his honor, view additional details about the memorial service, and pay tribute to him on an online memorial.  

About Cephalon, Inc.

Cephalon is a global biopharmaceutical company dedicated to discovering, developing and bringing to market medications to improve the quality of life of individuals around the world. Since its inception in 1987, Cephalon has brought first-in-class and best-in-class medicines to patients in several therapeutic areas. Cephalon has the distinction of being one of the world's fastest-growing biopharmaceutical companies, now among the Fortune 1000 and a member of the S&P 500 Index, employing approximately 4,000 people worldwide. The company sells numerous branded and generic products around the world. In total, Cephalon sells more than 150 products in nearly 100 countries. More information on Cephalon and its products is available at http://www.cephalon.com/

SOURCE Cephalon, Inc.